As aging populations and worsening air pollution contribute to a rising incidence of pulmonary diseases, conditions such as chronic obstructive pulmonary disease (COPD) and lung cancer have emerged as major global healthcare challenges. Traditional robotic-assisted surgical systems, while advancing minimally invasive techniques, often come with high costs and limited flexibility in the confined thoracic cavity, increasing the risk of complications such as pneumothorax and bleeding. These challenges underscore the need for more adaptable and safer surgical solutions.
To address these limitations, a research team led by Dr. Shu Huang at the Industrial Technology Research Institute (ITRI) has developed a novel Miniature Serpentine Robotic System System, called Miniature Serpentine Robotic System, pioneering a new era of minimally invasive and incision-free surgery. This breakthrough technology significantly enhances surgical precision and safety while reducing postoperative complications.
The Miniature Serpentine Robotic System features a micro-tubular robotic arm capable of four-directional movement, offering unparalleled dexterity and control. Unlike conventional rigid robotic systems, this flexible robotic arm is designed to navigate natural anatomical pathways, allowing for zero-incision procedures. The system incorporates an advanced one-piece molding design, providing high degrees of freedom with an angular range of up to 210°, enabling precise maneuvering in complex surgical environments.
By integrating 3D imaging technology and a coordinate-based positioning system, the robotic arm enables physicians to reach previously inaccessible areas deep within the lungs. This capability is particularly valuable for early-stage lung cancer diagnosis and minimally invasive treatment, including ablative techniques, significantly reducing risks such as pneumothorax, hemorrhage, and postoperative infections associated with traditional open or video-assisted thoracoscopic surgery (VATS).
Additionally, the system is equipped with real-time tactile feedback technology, utilizing miniature force sensors to continuously monitor and adjust the pressure exerted on tissues. This ensures that delicate lung structures remain unharmed, further enhancing surgical safety. The integration of this technology also minimizes radiation exposure during procedures, providing surgeons with a more intuitive and safer operating experience.
The Miniature Serpentine Robotic System has successfully completed preliminary validation through a collaboration with National Taiwan University Hospital, demonstrating its feasibility in ex vivo porcine lung models. Moving forward, the research team aims to extend clinical applications by working with leading medical institutions worldwide. Plans are underway to conduct extensive clinical trials to accelerate regulatory approvals and commercial adoption.
Dr. Huang emphasized that the team has developed three interchangeable modular components, catering to various medical specialties and surgical indications. These modules, which can be assembled in under a minute, streamline surgical workflows while minimizing sterilization complexities and infection risks. As the technology matures, the Miniature Serpentine Robotic System is poised to become a key player in the evolution of incision-free surgical interventions.
Future developments include the integration of soft ablative needle technology and mesenchymal stem cell therapy, aiming to provide a comprehensive treatment solution for lung diseases. Additionally, the team is actively engaged in preclinical safety and efficacy evaluations, ensuring compliance with international medical regulatory standards to facilitate market entry.
With its potential to revolutionize thoracic surgery, this pioneering robotic system is expected to transform the landscape of minimally invasive procedures, improving patient outcomes and expanding the frontiers of precision medicine.
Resource:《新創動態》軟性管狀手術機器人 人體孔道運行治療肺癌零傷口
